Essentials of Model-informed Drug Development in Oncology Blog Post
Model-informed drug development in oncology is critical to developing safer and more effective cancer drugs. Read the blog to learn more...
Model-informed drug development in oncology is critical to developing safer and more effective cancer drugs. Read the blog to learn more...
Rajesh Krishna proposes using an integrated clinical pharmacology & model-informed strategy for Alzheimer's disease clinical trials and drug development.
Drug repurposing is promoted as a cost- and time-effective mechanism for providing new medicines. Often, however, there is insufficient consideration by academic researchers of the processes required to ensure that a repurposed drug can be used for a new indication. This may explain the inability of drug repurposing to fulfill its promise.ll
In a world of rising healthcare costs, the greatest nightmare for payers is reimbursing drug interventions that do not meaningfully benefit their covered lives. Rare disease therapies, often viewed as attractive areas for pharmaceutical & biotech manufacturers, represent some of...
Streamline virology dataset organization with advanced SAS programming.
Follow 5 expert tips for creating a Summary of Changes (SOC) to streamline Investigator’s Brochure updates and manage medical writing more efficiently.